Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening

This study has been completed.
Sponsor:
Collaborator:
Agnelli Hospital, Italy
Information provided by:
University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT00482560
First received: June 4, 2007
Last updated: June 28, 2007
Last verified: June 2007

June 4, 2007
June 28, 2007
January 2007
Not Provided
Premature Infant Pain Profile (PIPP) scale rate (0-21) [ Time Frame: 15 seconds before and Within 30 seconds after heel lance ]
Same as current
Complete list of historical versions of study NCT00482560 on ClinicalTrials.gov Archive Site
  • Heart Rate Increase [ Time Frame: within 30 seconds after heel lance ]
  • Oxygen Saturation decrease [ Time Frame: within 30 seconds after heel lance ]
  • Duration of first cry [ Time Frame: within 2 minutes after heel lance ]
  • Percentage of crying time [ Time Frame: within 2 minutes after heel lance ]
  • Percentage of crying time [ Time Frame: During blood sampling ]
Same as current
Not Provided
Not Provided
 
Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening
Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening

The purpose of this study is to compare the antinociceptive effect of 1 ml of 30% sucrose solution vs breastfeeding on neonatal screening heel lance

Blood sampling heel lance for neonatal screening is the most frequent painful manoeuvre in Neonatal Units in healthy neonates.

Some techniques showed efficacy evidence in reducing pain response: sucrose solutions, breastfeeding during blood sampling, topical local anaesthetics.

A Cochrane Review in 2004 recommends the administration of sucrose 0.24-0.48 g (1-2 ml of 24% sucrose solution). It reduces PIPP scale rate about 20%.

Our purpose is to compare the antinociceptive effect of 1 ml 30% sucrose solution administered 2 minutes before heel lancing vs blood sampling heel lance during breastfeeding.

PIPP scale is a validated 7-indicator scale for the assessment of procedural pain in preterm and term neonates.

Informant consent was asked parents during consultation by a Pediatrician of the Neonatal Unit of the Hospital in the last months of pregnancy.

After parent written consent was obtained, 100 three day old neonates were randomized for treatment A (breastfeeding) or B (sucrose solution administration). The nurse opened consecutively numbered envelopes.

Timing of operators: Group A Breastfeeding

  • The heel of neonate was warmed up by a glove full of water at 40° C for 2 minutes.
  • Monitoring of Oxygen Saturation and Heart Rate.
  • The neonate was breastfed by the mother till the nurse watched a continuous active suction.
  • Administration of first phase of PIPP scale (15 seconds before heel lance).
  • Digital Voice Record started
  • Heel Lance with an automated piercing device .
  • Squeezing for blood sampling till filling 4 catch basins for neonatal screening. If necessary a new heel lance was practiced.
  • Administration of the second phase of PIPP scale.
  • Record of duration of blood sampling and collateral effects
  • Stop Digital Voice Recording

Group B Sucrose administration

  • The neonate was laid on a baby-changing table.
  • The heel of neonate was warmed up by a gloves full of water a 40° C for 2 minutes.
  • Oral administration of 1 ml of 30% sucrose solution.
  • Monitoring of Oxygen Saturation and Heart Rate.
  • Administration of first phase of PIPP scale (15 seconds before heel lance).
  • Digital Voice Record starts
  • Heel Lance with an automated piercing device.
  • Squeezing for blood sampling till filling 4 catch basins for neonatal screening. If necessary a new heel lance was practiced.
  • Administration of the second phase of PIPP scale.Record of duration of blood sampling and collateral effects.
  • Stop Digital Voice Recording

Blood sampling was practiced by skilled pediatric nurses. Registration of data, PIPP scale, voice record was made by a second operator, blind to the pur pose of the study.

A third blind operator collected paper data and checked voice record (outcome cry behaviour).

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Pain
  • Drug: Sucrose solution 30%1 ml
  • Behavioral: Breastfeeding
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
April 2007
Not Provided

Inclusion Criteria:

  • Term neonates, gestational age 37-42 weeks
  • Apgar >= 7
  • Not fed in the last 30 minutes
  • Informant consent

Exclusion Criteria:

  • Congenital malformation
  • Born in Caesarian Section in General Anaesthesia
  • Maternal use of opioids
  • Administration of Naloxone, Phenobarbital in the previous 48 hours
  • Impossibility of breastfeeding
Both
up to 5 Days
No
Contact information is only displayed when the study is recruiting subjects
Italy
 
NCT00482560
PRN19341
No
Not Provided
University of Turin, Italy
Agnelli Hospital, Italy
Principal Investigator: Luigi Codipietro, MD University of Turin Department of Paediatric Science Doctorate in Experimental Pediatry
Study Chair: Alberto Ponzone, MD University of Turin Department of Paediatric Science Doctorate in Experimental Pediatry
University of Turin, Italy
June 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP